What kind of genetic testing is recommended

LeukemiaOctober 27, 2025Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

For leukemia patients, genetic testing is a crucial part of diagnosis and treatment planning. Let me outline the key recommended genetic tests based on authoritative sources:

According to the NCCN Guidelines for Acute Myeloid Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL):

Core Molecular Testing:

Cytogenetic analysis (chromosome study)
Comprehensive genomic profiling including mutations in genes such as: • FLT3 • NPM1 • CEBPA • IDH1/IDH2 • TP53

The Leukemia & Lymphoma Society (LLS) specifically emphasizes that genetic testing should include:

Philadelphia chromosome testing (BCR-ABL1)
Next-generation sequencing (NGS) panels to detect multiple mutations
FISH (Fluorescence In Situ Hybridization) testing for specific chromosomal changes

According to the National Cancer Institute (NCI), genetic test results are essential because they:

Help determine your specific leukemia subtype
Guide treatment selection
Provide important prognostic information
May identify eligibility for targeted therapies or clinical trials

Important Note: The specific genetic tests recommended will depend on whether you have AML, ALL, CML, or CLL, as each type has different genetic markers. Please consult with your hematologist-oncologist about which specific tests are recommended for your type of leukemia, as they will be able to order the appropriate tests based on your individual case.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Upload Records →Ask About Your Case →